The Brattle Group analyzed the financial impact of inventory overstatements in a securities fraud case in the health care industry. Our analysis demonstrated that inventory misstatements were an inconsequential part of the overall scheme of the fraud, and that they did not cause material artificial inflation in the stock price or material damage to shareholders.